Glucagon-like peptide-1 (GLP-1) is a weekly injectable medication that stimulates insulin release, slows gastric motility, reduces appetite, and stabilizes blood sugar
It slows down gastric emptying, reduces hunger, and increases insulin production in response to food, helping with both glucose control and weight loss
If you become pregnant while on GLP-1 therapy, the standard medical recommendation is to discontinue the medication right away and work with your healthcare provider on a safe transition plan
Your digestive system is a tunnel from your mouth to your butt
Recommended for: patients new to GLP-1 therapy, patients with a history of nausea on prior weight loss medications, patients sensitive to medication side effects
Molecular Metabolism, 2019